Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Walgreens Boots Alliance Inc. Add to portfolio

NAS:WBA, Feb 21, 09:25 UTC

Latest NAS:WBA News

Filter your feed

Apply Filter

Wednesday, February 19


News

Better Buy: CVS vs. Walgreens Boots Alliance

WBA CVS

Better Buy: CVS vs. Walgreens Boots Alliance | NASDAQ. If you've been an investor in Walgreens Boots Alliance(NASDAQ: WBA) for the past five years, you haven't been thrilled with its performance. 2 Walgreens -- hasn't been much better over that same period. But the stock did have a positive year in 2019, returning 13.4%, and is down only 3.1% year-to-date in 2020. Walgreens missed earnings estimates in the first quarter, as its earnings per share (EPS) dropped 19.8% to $0.95 compared to the previous year's quarter, and net operating income dropped 27.6% to $1 billion. Walgreens appears to be on the right track with its cost-reduction plan and planned initiatives, but the company doesn't expect earnings growth in 2020 --and it remains to be seen how the company will execute on its plan going forward.

Read Full Details

Story Sources

nasdaq.com fool.com
Topics:
  • Business
  • Financial

Thursday, February 13


News

Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know

WBA

Walgreens Boots Alliance (WBA) closed at $53.57 in the latest trading session, marking a -1.65% move from the prior day. On that day, WBA is projected to report earnings of $1.47 per share, which would represent a year-over-year decline of 10.37%. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, February 11


News

Championing Global Health: Walgreens Boots Alliance New Global Sustainability Report Details Support for People Living with Cancer and Efforts to Improve Child and Maternal Health

WBA

Walgreens stores sponsored more than 1,800 health fairs in local communities where they provided flu clinics, diabetes screening and information on opioid safety and drug takeback during fiscal year ending August 31, 2019. "Our purpose at WBA is to help people live healthier and happier lives," said Ornella Barra, WBA’s co-chief operating officer and the chairman of the company’s Corporate Social Responsibility Committee. Expansion of In-Store Support for People Living with Cancer. For the past 20 years, Walgreens Boots Alliance and its businesses has sought to create innovative and meaningful support for cancer patients and their loved ones. For more than 10 years, Boots UK and Macmillan Cancer Support, one of the largest British charities, have worked together to train beauty consultants and pharmacists to deliver in-store advice to patients and customers on managing physical and emotional side effects of cancer and cancer treatments. "Being able to talk with a Boots pharmacist who understood what I was going through and could give me advice on how to manage my physical and emotional side effects helped me feel less lonely and gave me the confidence to tackle my diagnosis head on."

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Saturday, February 08


News

Walgreens Boots Alliance Is Near Its 52-Week Low: Is Now the Time to Buy?

WBA

Walgreens Boots Alliance (NASDAQ: WBA) isn't off to a good start in 2020. Although last year wasn't great, with the stock down 14% and coming nowhere near the S&P 500's gains of 30%, the stock has continued to fall this year and it's now getting close to its low for the past 12 months. It should be even less concerning given that a key part of the reason for the decline is that the company has been de-emphasizing tobacco products. Otherwise, the pharmacy retailer may have easily surpassed estimates. Although it's a narrow miss that's easily explainable, the stock has struggled to post gains since then as investors have been quick to push the sell button on the stock. Part of the reason is likely due to the company's results last year when Walgreens underwhelmed investors as well. When the bears are out and looking for a reason to sell shares of a company, it doesn't take much to sink a stock. Despite the bearishness, it's not all doom and gloom for Walgreens as the company can turn things around. For one thing, the company is making significant changes at its locations, including offering more services in-store that give customers a reason to visit the store themselves and buy products there, as opposed to buying online from a competitor.

Read Full Details

Story Sources

nasdaq.com fool.com
Topics:
  • Business
  • Financial
  • Entertainment

Friday, February 07


News

Walgreens (WBA) Down 2.2% Since Last Earnings Report: Can It Rebound?

WBA

It has been about a month since the last earnings report for Walgreens Boots Alliance (WBA). Will the recent negative trend continue leading up to its next earnings release, or is Walgreens due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. The Pharmaceutical Wholesale division’s quarterly sales were $6 billion, up 5.2% year over year (comparable sales were up 8.3% at CER on growth in the emerging markets and the United Kingdom).

Read Full Details

Topics:
  • Business
  • Financial
News

Capital Investment Advisory Services LLC Increases Stock Position in Walgreens Boots Alliance Inc (NASDAQ:WBA) – Slater Sentinel

WBA

Capital Investment Advisory Services LLC boosted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 34.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). SunTrust Banks lifted their price target on shares of Walgreens Boots Alliance from $58.00 to $60.00 and gave the company a “hold” rating in a report on Wednesday, December 18th. Walgreens Boots Alliance Inc has a 12 month low of $49.03 and a 12 month high of $74.94. The stock has a market cap of $46.93 billion, a PE ratio of 13.14, a price-to-earnings-growth ratio of 1.36 and a beta of 0.92.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, February 05


News

Walgreens Boots Alliance Names Richard Ashworth As President Of Walgreens

WBA

Walgreens Boots Alliance Names Richard Ashworth As President Of Walgreens | NASDAQ. (RTTNews) - Walgreens Boots Alliance Inc. (WBA) Wednesday said it has appointed Richard Ashworth as President of Walgreens. Ashworth will be responsible for developing the strategies and plans for all Walgreens operations and will have full responsibility for the leadership, development and management of the business. Previously, Ashworth served as President of Operations, Walgreens, and has held a variety of leadership positions with increasing responsibility overseeing pharmacy, health care commercial, retail and other segments during his 28-year tenure with the company. "Richard is a strong leader who grew up with the Walgreens brand and who has a great appreciation for its storied heritage. He truly understands our customers and is passionate about the role we play in their daily lives," said Stefano Pessina, Executive Vice Chairman and CEO, Walgreens Boots Alliance. "We are pleased to have Richard lead the Walgreens business, and lead the charge as we create the Walgreens of the future. His experience will be incredibly valuable as we continue to accelerate our ongoing transformation to best meet the needs of our customers, communities and team members."

Read Full Details

Topics:
  • Business
  • Politics
  • Financial
  • Health
News

Boots UK chair and long-standing exec Elizabeth Fagan steps down

WBA

Boots UK chair and long-standing exec Elizabeth Fagan steps down. Boots’ first UK chair Elizabeth Fagan has stepped down from the retailer after less than two years in the role. Fagan, who has acted as non-executive chair for Boots since September 2018, has stepped down to pursue a broader non-executive portfolio, according to Insider Media. Her departure comes amid speculation that Wagreens Boots Alliance owner Stefano Pessina is considering taking the company private, and has reportedly been approached by private equity firm KKR in what could be the largest leveraged buyout on record.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, February 04


News

Walgreens to pay $7.5 million in settlement over phony Bay Area pharmacist

WBA

FILE - This June 24, 2019 file photo shows an exterior view of a Walgreens store in Los Angeles. OAKLAND — Walgreens will pay $7.5 million to settle with California authorities after an employee was criminally charged with impersonating a pharmacist and illegally filling more than 745,000 prescriptions in the San Francisco Bay Area. Prosecutors said that from late 2006 through 2017, Le used the license numbers of registered pharmacists in order to impersonate them and dispense prescriptions at Walgreens stores in Santa Clara and Alameda counties. The company will pay $7.5 million in penalties, costs and remedial payments.

Read Full Details

Topics:
  • Business
  • Health
  • Entertainment
  • Science
  • Financial
  • US
News

Walgreens to pay $7.5M in settlement over phony pharmacist - AOL Finance

WBA

OAKLAND, Calif. (AP) — Walgreens will pay $7.5 million to settle with California authorities after an employee was criminally charged with impersonating a pharmacist and illegally filling more than 745,000 prescriptions in the San Francisco Bay Area. Prosecutors said that from late 2006 through 2017, Le used the license numbers of registered pharmacists in order to impersonate them and dispense prescriptions at Walgreens stores in Santa Clara and Alameda counties. Walgreens Boots Alliance will acquire Rite Aid for $9.4 billion in cash in a deal announced today that combines the largest U.S. drugstore chain Walgreens with the nation's third largest. Full service in a wide range of retail fields at the new Walgreen drug stores; in new Villa includes a Walgreen tradition of full prescription services, at low cost made possible by the firm's Specialization in the field.

Read Full Details

Topics:
  • Business
  • Health
  • Science
  • Financial